HANSOH PHARMA(03692),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

03692 HANSOH PHARMA

Trading 09-01 09:30:21

35.600

+0.260

+0.74%

High35.680	Low35.200	Vol307.39K
Open35.680	D1 Closing35.340	Amplitude1.36%
Mkt Cap215.88B	Tradable Cap215.88B	Total Shares6.06B
T/O10.91M	T/O Rate0.01%	Tradable Shares6.06B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"03692","market":"HK","secType":"STK","nameCN":"HANSOH PHARMA","latestPrice":35.6,"timestamp":1788226214779,"preClose":35.34,"halted":0,"volume":307394,"delay":0,"changeRate":0.007357102433503055,"floatShares":6064000000,"shares":6064000000,"eps":1.0849817745690569,"marketStatus":"Trading","change":0.26,"latestTime":"09-01 09:30:21","open":35.68,"high":35.68,"low":35.2,"amount":10906659,"amplitude":0.013582,"askPrice":35.6,"askSize":66000,"bidPrice":35.26,"bidSize":16000,"shortable":3,"etf":0,"ttmEps":1.2922751258064265,"tradingStatus":2,"nextMarketStatus":{"tag":"Noon Closed","tradingStatus":4,"beginTime":1788235200000},"marketStatusCode":2,"adr":0,"listingDate":1560441600000,"exchange":"SEHK","adjPreClose":35.34,"dividendRate":0.013873,"openAndCloseTimeList":[[1788226200000,1788235200000],[1788238800000,1788249600000]],"volumeRatio":5.753367,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/03692","defaultTab":"news","newsList":[{"id":"1110873250","title":"JPMorgan Reaffirms 'Overweight' on Hansoh Pharma, Lifts Target Price to HK$50","url":"https://stock-news.laohu8.com/highlight/detail?id=1110873250","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110873250?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:20","pubTimestamp":1788168025,"startTime":"0","endTime":"0","summary":"JPMorgan has released a research report maintaining its \"Overweight\" rating on Hansoh Pharma (03692). Based on the company's first-half performance, the bank has raised its full-year collaboration...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0203347892.USD","IE00BJTD4V19.USD","LU0964807845.USD","LU0345770308.USD","IE00BDRTCR15.USD","LU1496350502.SGD","IE00BLSP4239.USD","LU0640476718.USD","LU1116320737.USD","IXG","BK4516","JPM","LU0345770993.USD","IE0034235303.USD","BK1191","LU0417517546.SGD","LU2430703095.HKD","LU2746668461.USD","IE00BK4W5M84.HKD","LU0048584097.USD","LU2456880835.USD","LU2237443549.SGD","LU0496365809.HKD","LU0787776722.HKD","BK4534","LU2430703251.USD","LU0859254822.USD","LU1244550221.USD","JPO","IE00BJLML261.HKD","LU2242649171.HKD","LU0689472784.USD","LU0170899867.USD","UYG","IYG","LU0971096721.USD","LU0070302665.USD","LU0976567544.SGD","LU0203345920.USD","LU1162221912.USD","LU2211815571.USD","LU2168564149.EUR","IE0034235188.USD","LU1145028129.USD","LU0820561909.HKD","LU0211326839.USD","IE00BZ1G4Q59.USD","LU1894683264.USD","LU0208291251.USD","LU0106261372.USD","LU1496350171.SGD","LU0211326755.USD","IE00B1XK9C88.USD","LU2213496289.HKD","LU0006306889.USD","LU1363072403.SGD","LU2746668974.SGD","LU0265550946.USD","LU1988902786.USD","LU0256863902.USD","LU2592432038.USD","IE00BKVL7J92.USD","LU0211328371.USD","LU1084165304.USD","IE00B3S45H60.SGD","LU1366192091.USD","FTXO","LU0323591593.USD","LU0868494708.USD","LU0149725797.USD","BK4533","LU2505996681.GBP","LU0256863811.USD","LU2552382132.HKD","LU0234570918.USD","LU1668664300.SGD","LU2756315664.SGD","IE00BYXW3230.USD","EWH","IE00B775SV38.USD","VFH","IE00B1BXHZ80.USD","LU2552382215.SGD","LU2168564495.EUR","LU1720051108.HKD","IE00BDCRKT87.USD","LU1670627923.USD","LU2552382058.USD","LU0943347566.SGD","BK4207","IE0034235295.USD","LU0320765489.SGD","LU0345769128.USD","BK4566","LU1894683348.USD","LU2168564222.USD","SG9999002232.USD","IE00BHPRN162.USD","IE00BKDWB100.SGD","LU2430703178.SGD","LU2462157665.USD","BK4588","LU0238689110.USD","LU2168563687.JPY","LU2357627491.SGD","LU2023250504.SGD","LU0310799852.SGD","IE00BLSP4452.SGD","LU1670628061.USD","BK1583","IE000M9KFDE8.USD","LU0211331839.USD","LU0345769631.USD","LU1917777945.USD","FNCL","LU2381873111.SGD","LU2505996509.AUD","IE00BK4W5L77.USD","LU2237443465.HKD","LU0211327993.USD","LU1116320901.HKD","LU0868494617.USD","BK4504","LU0820562030.AUD","LU1551013342.USD","LU1244550494.USD","XLF","IE00BN8TJ469.HKD","LU1629891620.HKD","TFNS","LU0683600562.USD","LU1548497426.USD","LU1974910355.USD","LU2756315318.SGD","LU0106831901.USD","LU2417539215.USD","LU0265550359.USD","LU0882574139.USD","LU2237443895.HKD","LU1280957306.USD","JPMO","LU0251132253.USD","LU1720051017.SGD","LU1551013425.SGD","LU2168564065.EUR","LU2237443382.USD","LU0320765646.SGD","IYF","LU1244550577.SGD","LU2237443622.USD","LU1119994496.HKD","LU0942090050.USD","LU2264538146.SGD","LU2357305700.SGD","LU2023250843.SGD","BK1589","TRUF","IE00BJTD4N35.SGD","IE00BFXG1179.USD","LU2236285917.USD","03692","LU0820561818.USD","BK4550","KBWB","BK4585","LU2054465674.USD","LU2106854487.HKD","LU1032466523.USD","IE00BWXC8680.SGD","LU1914381329.SGD","LU0234572021.USD","LU0267386448.USD","LU1267930490.SGD","IE00BBT3K403.USD","LU2023250330.USD","SG9999002224.SGD","BK4581","LU0187121727.USD","LU0215105999.USD","LU2244417387.USD","LU2237443978.SGD","LU1064131342.USD","LU1261432733.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663607305","title":"Hansoh Pharmaceutical Group Stock Sheds 3.8% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2663607305","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663607305?lang=en_us&edition=fundamental","pubTime":"2026-08-31 16:32","pubTimestamp":1788165120,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Hansoh Pharmaceutical Group Co. Ltd. shed 3.8% to 35.34 Hong Kong dollars on what proved to be an all-around dismal trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.1% to 25566.99.This was the stock's second consecutive day of losses.Hansoh Pharmaceutical Group Co. Ltd. closed 20% short of its 52-week high of HK$44.22, which the company reached Jan. 15.Trading volume totaled 18.3 million shares, compared to the 50-day average of 13.0 million shares.Data source: Dow Jones Market Data, FactSet","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","BK1191","BK1583","03692"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135796636","title":"Movement Alert｜HANSOH PHARMA Falls 3.16% in Regular Trading, Post-Earnings Profit-Taking Meets Broad Pharma Sector Weakness","url":"https://stock-news.laohu8.com/highlight/detail?id=1135796636","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135796636?lang=en_us&edition=fundamental","pubTime":"2026-08-31 09:49","pubTimestamp":1788140957,"startTime":"0","endTime":"0","summary":"On August 31, HANSOH PHARMA fell 3.16% in regular trading, trading at HK$35.20 per share, with turnover of approximately HK$105 million. The decline reflects a continuation of post-earnings...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"HANSOH PHARMA Falls on Post-Earnings Profit-Taking","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03692"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663019048","title":"Here's What Analysts Are Forecasting For Hansoh Pharmaceutical Group Company Limited (HKG:3692) After Its Half-Year Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2663019048","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663019048?lang=en_us&edition=fundamental","pubTime":"2026-08-29 06:17","pubTimestamp":1787955476,"startTime":"0","endTime":"0","summary":"Shareholders of Hansoh Pharmaceutical Group Company Limited ( HKG:3692 ) will be pleased this week, given that the...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3692/hansoh-pharmaceutical-group-shares/news/heres-what-analysts-are-forecasting-for-hansoh-pharmaceutica","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3692/hansoh-pharmaceutical-group-shares/news/heres-what-analysts-are-forecasting-for-hansoh-pharmaceutica","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["VGFPF","VOTE","03692","JOYT","RGLO","DECU","BK1583","PMDE","FEBU","BK1191","GXDW","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662951720","title":"China's Zhaoke Ophthalmology H1 Revenue Rises","url":"https://stock-news.laohu8.com/highlight/detail?id=2662951720","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662951720?lang=en_us&edition=fundamental","pubTime":"2026-08-28 21:24","pubTimestamp":1787923484,"startTime":"0","endTime":"0","summary":"China's Zhaoke Ophthalmology H1 revenue risesOverviewChina ophthalmic drug maker's interim revenue rose yr/yr to RMB 18.8 mlnNon-HKFRS adjusted loss for the period widened slightly to RMB 116.1 mlnCom","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nL1N44P0JF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1209","BK1589","BK1191","BK1583","03692","BK1574","BK1161","02219","02616","BK1587","06622"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662046377","title":"China's CStone Pharmaceuticals H1 Revenue Soars on Drug Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2662046377","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662046377?lang=en_us&edition=fundamental","pubTime":"2026-08-27 19:40","pubTimestamp":1787830849,"startTime":"0","endTime":"0","summary":"China's CStone Pharmaceuticals H1 revenue soars on drug salesOverviewChina biopharma firm's half-year revenue rose 315% yr/yr to RMB205.1 mlnRevenue growth driven by higher pharmaceutical sales, espec","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL1N44O0IS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK0216","688796","LU0502904849.HKD","01801","03692","LU2242644610.SGD","LU2097828474.EUR","HK0000165453.HKD","LU0244354667.USD","LU2097828714.EUR","BK1589","LU1188198961.HKD","LU2097828631.EUR","LU2488822045.USD","BK1574","LU0455707207.USD","LU0463099449.HKD","LU2097828557.USD","BK1161","LU2097828805.USD","LU2328871848.SGD","LU1969619763.USD","LU0326950275.SGD","BK1191","KURE","02616"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662708043","title":"China's JW Therapeutics Interim Revenue Rises 4.7% on Carteyva Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2662708043","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662708043?lang=en_us&edition=fundamental","pubTime":"2026-08-27 18:08","pubTimestamp":1787825320,"startTime":"0","endTime":"0","summary":"China's JW Therapeutics interim revenue rises 4.7% on Carteyva salesOverviewChina cell immunotherapy developer's interim revenue grew 4.7% yr/yr, driven by Carteyva salesGross profit margin improved t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL1N44O0DW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1188198961.HKD","02126","LU0310799852.SGD","GLAM","IBB","PPH","01801","LU0949170772.SGD","IE0004445239.USD","IXJ","LU0868494617.USD","LU2362541513.USD","LU1934455863.HKD","JDOC","IE00BN8TJ469.HKD","LU0708994859.HKD","LU2237443382.USD","XLV","LU0859254822.USD","ABBV","REGN","IBBQ","LU0395794307.EUR","LU0463099449.HKD","RXL","LU1934455277.USD","CMI","FTXH","TBXU","IYH","TRUH","688331","LU0432979614.USD","MEDX","LU2237443978.SGD","VHT","LU1244550577.SGD","03692","IE00BVYPNV92.GBP","PJP","IE000SO60NU8.SGD","LU1037948897.HKD","LU2097828714.EUR","BBH","LU0943347566.SGD","BK1574","AGNG","FHLC","MADE","KURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165986970","title":"Goldman Sachs Boosts HANSOH PHARMA Price Target on Strong First-Half Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1165986970","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165986970?lang=en_us&edition=fundamental","pubTime":"2026-08-27 17:32","pubTimestamp":1787823160,"startTime":"0","endTime":"0","summary":"Goldman Sachs has released a research report indicating that HANSOH PHARMA (03692) delivered first-half results that surpassed expectations, driven by innovative drug sales, operational leverage, and...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03692","BK1589","BK1191","BK1583","EWH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180170599","title":"Why Hansoh Pharma Surged Over 16% After Its Earnings Report?","url":"https://stock-news.laohu8.com/highlight/detail?id=1180170599","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180170599?lang=en_us&edition=fundamental","pubTime":"2026-08-27 17:10","pubTimestamp":1787821837,"startTime":"0","endTime":"0","summary":"On August 27, Hansoh Pharma (03692.HK) saw its share price surge over 16% intraday, following the release of its 2026 interim results the previous day. The company reported first-half revenue of RMB...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","BK1583","03692","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662774568","title":"Biocytogen Pharmaceuticals H1 Revenue up 51.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662774568","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662774568?lang=en_us&edition=fundamental","pubTime":"2026-08-27 16:41","pubTimestamp":1787820113,"startTime":"0","endTime":"0","summary":"Biocytogen Pharmaceuticals H1 revenue up 51.6%OverviewChina biotech firm's H1 revenue rose 51.6% yr/yr to RMB941.4 mlnNet profit attributable to shareholders up 402.3% to RMB241.1 mlnCompany cites str","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL1N44O0B0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","688796","LU0051755006.USD","01801","LU0502904849.HKD","LU3063872942.SGD","LU0359202008.SGD","LU0516422440.USD","LU0823426480.USD","03692","BK1521","LU0572944931.SGD","LU2097828474.EUR","LU1794554557.SGD","LU0244354667.USD","LU0823426308.USD","LU2039709279.SGD","IE00B0JY6N72.USD","LU0417516902.SGD","LU2097828631.EUR","LU0516422366.SGD","LU0140636845.USD","LU0819121731.USD","LU0128526141.USD","LU1880383366.USD","LU1242518857.USD","LU0417516738.SGD","LU2488822045.USD","LU0455707207.USD","LU0463099449.HKD","LU0588546209.SGD","LU1720050803.USD","LU0039217434.USD","LU0516423091.SGD","BK1576","LU0348735423.USD","LU0979878070.USD","LU0516423174.USD","BK1161","LU2097828805.USD","LU2328871848.SGD","LU0856984785.SGD","BK1191","LU0307460666.USD","02269","LU0456846285.SGD","KURE","LU0348825331.USD","02315","LU0320764599.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662774771","title":"Hansoh Pharmaceutical Group Stock Advances 16% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2662774771","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662774771?lang=en_us&edition=fundamental","pubTime":"2026-08-27 16:31","pubTimestamp":1787819460,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Hansoh Pharmaceutical Group Co. Ltd. climbed 16% to 36.82 Hong Kong dollars on what proved to be an all-around grim trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.3% to 25565.74.This was the stock's third consecutive day of gains.Hansoh Pharmaceutical Group Co. Ltd. closed 17% short of its 52-week high of HK$44.22, which the company reached Jan. 15.Trading volume totaled 33.6 million shares, compared to the 50-day average of 12.3 million shares.Data source: Dow Jones Market Data, FactSet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","03692","BK1583","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662720393","title":"China's Hansoh Pharmaceutical Jumps Most on Record on H1 Profit Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2662720393","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662720393?lang=en_us&edition=fundamental","pubTime":"2026-08-27 12:54","pubTimestamp":1787806454,"startTime":"0","endTime":"0","summary":"BUZZ-China's Hansoh Pharmaceutical jumps most on record on H1 profit growth** Shares of China's Hansoh Pharmaceutical Group3692.HKjump 15.4% to HK$36.62, set for biggest one-day pct rise since debut in June 2019** Stock hits the highest level since May 14 in the third straight session of gain** Top pct gainer in the Hang Seng Biotech Index.HSBIO, which gains 0.1%** The oncology and metabolic disease specialist, a RocheROPC.Spartner, reported a near 36% rise infirst-half profit, driven by strong growth in sales of innovative medicines and higher investment income** Hansoh posted net profit of 4.26 billion yuan  for the six months ended in June, up from 3.13 billion yuan a year earlier and beating HSBC Qianhai Securities forecast of about 2.9 billion yuan** YTD, stock up 0.6%, while the Hang Seng Biotech Index.HSBIOup 13.9%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL1N44O04I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HSBA.UK","IE0034235071.USD","LU1023061473.USD","LU1770036033.HKD","LU0215105999.USD","LU0516422952.EUR","LU0572940350.SGD","LU0964806797.USD","BK5152","LU0348814723.USD","03692","LU0164880469.USD","LU0348816934.USD","LU1170363599.USD","LU1105468828.SGD","LU0540923850.HKD","LU0171293334.USD","LU0516422440.USD","LU1051770623.HKD","LU0417516738.SGD","LU1153584641.USD","LU2293690082.USD","LU0516423091.SGD","LU0345776255.USD","LU0588546209.SGD","LU1046234339.USD","LU0348735423.USD","LU0857590862.USD","LU0171281750.USD","LU1003076772.USD","LU0918141887.USD","LU0109981661.USD","LU0149534421.HKD","LU0797268264.HKD","LU0898667661.SGD","LU0307460666.USD","LU0634319403.HKD","LU2114397693.USD","LU0575583348.USD","LU0920840948.USD","LU1282648689.USD","LU0920783379.SGD","LU0516422366.SGD","LU0827474353.SGD","LU0310799852.SGD","LU1481107354.HKD","LU1023061713.HKD","LU0264606111.USD","BK1191","LU0572939691.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158953188","title":"Movement Alert｜HANSOH PHARMA Rises 5.73% in Regular Trading, H1 Net Profit Surges 35.8% Year-over-Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1158953188","media":"Market Focus","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158953188?lang=en_us&edition=fundamental","pubTime":"2026-08-27 09:31","pubTimestamp":1787794271,"startTime":"0","endTime":"0","summary":"On August 27, HANSOH PHARMA rose 5.73% in regular trading, trading at 34.12 HKD/share, with turnover of HK$51.35 million.On the news front, the company released its interim results after market close...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"HANSOH PHARMA Jumps as H1 Net Profit Surges 35.8%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03692"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662745499","title":"Stronger Half Year Earnings And Profitability Could Be A Game Changer For Hansoh (SEHK:3692)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662745499","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662745499?lang=en_us&edition=fundamental","pubTime":"2026-08-26 22:20","pubTimestamp":1787754056,"startTime":"0","endTime":"0","summary":"Hansoh Pharmaceutical Group Company Limited has reported past half-year results to June 30, 2026, with sales rising to CNY 8,304.01 million and net income increasing to CNY 4,257.94 million, lifting basic and diluted EPS from continuing operations to CNY 0.70.\nThe combination of higher revenue and a larger increase in net income suggests improved profitability and operating efficiency in Hansoh’s core business.\nWe will now explore how this improvement in earnings and profitability shapes...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3692/hansoh-pharmaceutical-group-shares/news/stronger-half-year-earnings-and-profitability-could-be-a-gam","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-3692/hansoh-pharmaceutical-group-shares/news/stronger-half-year-earnings-and-profitability-could-be-a-gam","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1191","BK1589","BK1583","03692"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662717592","title":"Grand Pharmaceutical H1 Revenue Rises on Nuclear Medicine Demand","url":"https://stock-news.laohu8.com/highlight/detail?id=2662717592","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662717592?lang=en_us&edition=fundamental","pubTime":"2026-08-26 21:54","pubTimestamp":1787752465,"startTime":"0","endTime":"0","summary":"Grand Pharmaceutical H1 revenue rises on nuclear medicine demandOverviewHong Kong-listed pharma group's H1 revenue rose 3.2% yr/yr to HK$6.39 blnNet income attributable to owners fell to HK$1.06 bln f","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nL1N44N0MX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","00512","BK1589","BK1600","00460","BK1593","03692","BK1515","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176595817","title":"HANSOH PHARMA lowers CB conversion price to HK$56.54, potential share issuance up 1.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1176595817","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176595817?lang=en_us&edition=fundamental","pubTime":"2026-08-26 21:03","pubTimestamp":1787749383,"startTime":"0","endTime":"0","summary":"Hansoh Pharmaceutical Group Company Limited (HANSOH PHARMA) will adjust the conversion price of its HK$4.68 billion zero-coupon convertible bonds (due 2033) following the interim dividend record date...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03692"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662279711","title":"Hansoh Pharmaceutical Cuts Convertible Bond Conversion Price to Hk$56.54 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2662279711","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662279711?lang=en_us&edition=fundamental","pubTime":"2026-08-26 20:46","pubTimestamp":1787748384,"startTime":"0","endTime":"0","summary":"Hansoh Pharmaceutical cuts convertible bond conversion price to HK$56.54 per shareHansoh Pharmaceutical adjusted the conversion price on its HK$ 4.68 billion zero-coupon convertible bonds due 2033.Con","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDLc9h2j6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","03692","BK1583","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662715194","title":"China's Zhongzhi Pharmaceutical H1 Revenue Falls 10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662715194","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662715194?lang=en_us&edition=fundamental","pubTime":"2026-08-26 19:36","pubTimestamp":1787744170,"startTime":"0","endTime":"0","summary":"China's Zhongzhi Pharmaceutical H1 revenue falls 10%OverviewChina pharmaceutical maker's half-year revenue fell 10.3% yr/yrProfit attributable to owners rose 3.8% yr/yrGross profit and margin declined","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nL1N44N0G0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00460","BK1583","BK1606","BK1600","01681","BK1515","03692","BK1589","BK1593","BK1191","03737"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662797145","title":"Uni-Bio Science H1 Revenue Falls 12% on Pricing Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=2662797145","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662797145?lang=en_us&edition=fundamental","pubTime":"2026-08-26 18:18","pubTimestamp":1787739506,"startTime":"0","endTime":"0","summary":"Uni-Bio Science H1 revenue falls 12% on pricing changesOverviewHong Kong-listed biopharma firm's H1 2026 revenue fell 12% yr/yr amid pricing adjustmentsNet profit dropped 59% as R+D and commercializat","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nL1N44N0D4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE000MB6IJN5.SGD","LU0203347892.USD","MEDX","LU2129689605.HKD","LU2133065610.SGD","IE00B2B36J28.USD","AGNG","IE00BSNM7G36.USD","IE000BZT7R73.USD","LU0868494708.USD","IE0009355771.USD","ABBV","XLV","KURE","FTXH","FHLC","LU2347655073.USD","SG9999015986.USD","LU0820561909.HKD","LU0122379950.USD","IE0002270589.USD","IXJ","LU1989772840.SGD","GLAM","LU0211328371.USD","00690","688331","JDOC","BK4581","LU0234572021.USD","03692","BK1191","IE00BLSP4452.SGD","LU1934455277.USD","LU0057025933.USD","IE000WAW04H5.SGD","IE00B19Z3581.USD","PPH","VHT","LU0211327993.USD","RXL","BK1583","IYH","BK4588","LU0985320562.USD","01801","PJP","TRUH","BK4533","LU0203345920.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139887525","title":"Hansoh Pharma Declares HKD 0.285 Interim Dividend for First Half of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1139887525","media":"Bulletin Express","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139887525?lang=en_us&edition=fundamental","pubTime":"2026-08-26 17:41","pubTimestamp":1787737291,"startTime":"0","endTime":"0","summary":"Hansoh Pharmaceutical Group Company Limited (Hansoh Pharma) has announced an interim ordinary dividend of HKD 0.285 per share for the six months ended 30 June 2026, payable out of the financial year...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03692"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.1378},{"period":"1month","weight":0.0982},{"period":"3month","weight":0.1465},{"period":"6month","weight":0.1114},{"period":"1year","weight":-0.006},{"period":"ytd","weight":-0.0143}],"compareEarnings":[{"period":"1week","weight":0.0019},{"period":"1month","weight":-0.0123},{"period":"3month","weight":-0.0181},{"period":"6month","weight":0.0126},{"period":"1year","weight":0.0195},{"period":"ytd","weight":-0.0025}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Hansoh Pharmaceutical Group Company Ltd is an investment holding company primarily engaged in the research and development, production and sale of a series of pharmaceutical products. The Company’s innovative drug products include Ameile, Hansoh Xinfu, Mailingda, Fulaimei, Hengmu, XINYUE, Saint Luolai and other products. The Company’s drug products are mainly used in oncology, anti-infective diseases, central nervous system (CNS) diseases, metabolic diseases and other therapeutic areas. The Company mainly conducts its business in the domestic market.","yearOnYearQuotes":[{"month":1,"riseRate":0.714286,"avgChangeRate":-0.002557},{"month":2,"riseRate":0.428571,"avgChangeRate":-0.012842},{"month":3,"riseRate":0.428571,"avgChangeRate":0.023369},{"month":4,"riseRate":0.571429,"avgChangeRate":0.033966},{"month":5,"riseRate":0.571429,"avgChangeRate":-0.005203},{"month":6,"riseRate":0.571429,"avgChangeRate":0.039397},{"month":7,"riseRate":0.625,"avgChangeRate":0.011389},{"month":8,"riseRate":0.75,"avgChangeRate":0.028865},{"month":9,"riseRate":0.571429,"avgChangeRate":-0.033022},{"month":10,"riseRate":0.142857,"avgChangeRate":0.0016},{"month":11,"riseRate":0.714286,"avgChangeRate":0.063448},{"month":12,"riseRate":0.571429,"avgChangeRate":0.016866}],"exchange":"SEHK","name":"HANSOH PHARMA","nameEN":"HANSOH PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.48.0","shortVersion":"4.48.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"HANSOH PHARMA(03692),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest HANSOH PHARMA(03692) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"HANSOH PHARMA,03692,HANSOH PHARMA股票,HANSOH PHARMA股票老虎,HANSOH PHARMA股票老虎国际,HANSOH PHARMA行情,HANSOH PHARMA股票行情,HANSOH PHARMA股价,HANSOH PHARMA股市,HANSOH PHARMA股票价格,HANSOH PHARMA股票交易,HANSOH PHARMA股票购买,HANSOH PHARMA股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"HANSOH PHARMA(03692),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest HANSOH PHARMA(03692) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}